A recent study shows that miR-520 h promotes the drug resistance of human breast cancer cells through protecting cells from paclitaxel-induced apoptosis by targeting death-associated protein kinase 2 (DAPK2) (Su et al., 2017). This evidence concerns the gene DAPK2 and breast cancer.